ScholarIQanswers from OpenAlex

α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa

PaperCitations, authors & open-access status

α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa is a paper indexed in ScholarIQ from OpenAlex.

How many citations does α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa have?

ScholarIQcitation count

α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa has 18 citations in the OpenAlex counts ScholarIQ stores.

When was α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa published?

ScholarIQyear

α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa has 2018 year in the ScholarIQ index.

What is the open-access status of α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa?

ScholarIQoa status

α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa has closed oa status in the ScholarIQ index.

What is the DOI of α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa?

ScholarIQdoi

The DOI for α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa is on the source record.

What is the PMID of α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa?

ScholarIQpmid

The PMID for α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa is on the source record.

What is the OpenAlex record for α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa?

ScholarIQopenalex

The OpenAlex for α‐Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial